The expanding list of drugs and medical consumables included in China's bulk-buy program is expected to cover traditional Chinese medicines and more orthopedic and dental implants this year, the National Healthcare Security Administration said on Friday.
February 14, 2022China's reform of centralized volume-based procurement of drugs and high-value medical consumables has helped save the country and patients over 260 billion yuan (US$40.86 billion) over the past three years, according to an official at an SCIO press briefing.
February 11, 2022China will carry out centralized bulk-buying of drugs and high-value medical consumables on a regular and institutionalized basis, to further lower medical costs for patients, according to a decision made at the State Council's Executive Meeting chaired by Premier Li Keqiang on Monday.
January 12, 2022